Skip to main content

Table 1 Patients’ characteristics and outcomes

From: Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study

 

On ICU admission

At the time of CEUS study

Outcomes

Patient number

Age, years

Main diagnosis

Chronic kidney disease

Diabetes

Hypertension

APACHE-III score

Mechanical ventilation

RIFLE

NA dosage (μg/minute)

Time on NA (hrs)

Other inotropes

ACE Inh < 48 h

Diuretics < 48 hrs

ICU LOS, days

RIFLE

RRT

Death

1

51

Septic shock

No

No

No

65

Yes

R

13

46

Milrinone

No

No

6

F

No

No

2

64

Septic shock

No

Yes

No

47

No

-

6

20

No

Yes

Yes

5

R

No

No

3

30

Septic shock

No

No

No

18

Yes

-

3.5

6

No

No

No

4

I

No

No

4

71

Septic shock

No

No

No

57

No

R

4

26

No

No

No

2

I

No

No

5

84

Septic shock

No

No

Yes

73

Yes

R

14

52

No

No

Yes

10

R

No

Yes

6

42

Status epilepticus

No

No

No

24

Yes

R

10

48

No

No

Yes

12

R

No

No

7

68

Septic shock

No

Yes

Yes

60

No

-

2

17

No

No

No

3

-

No

No

8

63

Septic shock

No

No

No

61

Yes

I

15

19

No

No

No

4

I

No

No

9

32

Septic shock

No

No

No

56

No

-

11

5

No

No

No

2

R

No

No

10

71

Septic shock

No

No

Yes

44

No

F

10

21

No

No

No

2

F

No

Yes

11

62

Septic shock

No

No

No

80

No

I

16

8

Vasopressin

No

No

7

I

No

No

12

65

Cardiogenic shock

No

No

No

75

Yes

-

8

16

No

No

Yes

4

-

No

No

  1. APACHE, acute physiology and chronic health evaluation; NA, noradrenaline; RIFLE, risk, injury, failure, loss, end-stage kidney failure; ACE Inh, angiotensin converting enzyme inhibitors; LOS, length of stay; RRT, renal replacement therapy.